Actas de congresos
The Challenges Of Ractopamine Use In Meat Production For Export To European Union And Russia
Registro en:
Food Control. Elsevier Sci Ltd, v. 72, p. 289 - 292, 2017.
0956-7135
1873-7129
WOS:000390633500018
10.1016/j.foodcont.2015.10.015
Autor
Nino
Alfredo M. M.; Granja
Rodrigo H. M. M.; Wanschel
Amarylis C. B. A.; Salerno
Alessandro G.
Institución
Resumen
beta-adrenergic agonist ractopamine is increasingly used in the swine industry due to consumer demand for leaner pork products. Ractopamine redirects nutrients to favor leanness rather than fat deposition, improves growth and carcass traits of finishing pigs. However, countries around the world are split over whether to allow the use of ractopamine in meat production. While this substance has been authorized as a feed additive in a limited number of countries, in pigs and cattle, the vast majority of jurisdictions, including the European Union (EU), China, Taiwan, Russia has banned its use on safety grounds. This legal division finds reflection into the long-standing opposition existing between countries supporting the establishment of maximum residue levels and those who oppose it within the Codex. In fact, the international debate over ractopamine bans, restrictions and maximum residue level standards have intensified and a trade war may be looming. A conflicting debate between countries has started. In this article, we discuss about the criteria of "level and not a limit", comprehensive methods used for ractopamine monitoring on every stage of the production chain, and the recommended tissue for analysis. (C) 2015 Elsevier Ltd. All rights reserved. 72 289 292 FAO/IAEA International Symposium on Food Safety and Quality - Applications of Nuclear and Related Techniques NOV 10-13, 2014 Vienna, AUSTRIA